AFTER MONTH 1, THE DOSAGE PER INJECTION INCREASES GRADUALLY IN MONTH 2, 3, AND 4
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
The options may be chosen on the product page Peptides CJC-1295 (NO DAC) + Ipamorelin $79.99 Select options This product has multiple variants
Sterile Technique Essentials Never reuse syringes or needles
Always disclose your medical history to ensure safety
Cell 184 , 25372564 (2021)